product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Chemerin Antibody (13G2) [FITC]
catalog :
NBP2-21989F
quantity :
0.1 ml
price :
539 USD
clonality :
monoclonal
host :
rat
conjugate :
FITC
clone name :
13G2
reactivity :
human, mouse
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP2-21989F
SKU :
NBP2-21989F
product name :
Chemerin Antibody (13G2) [FITC]
sizes available :
0.1 ml
description :
The Chemerin Antibody (13G2) [FITC] from NBP2-21989F is a 5.8e-05 antibody to . This antibody reacts with mouse.
target :
Chemerin
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
13G2
conjugate :
FITC
all_available conjugate :
PE;mFluor Violet 450 SE;FITC
dilution :
ELISA
host :
Rat
immunogen :
Mouse recombinant Chemerin
isotype :
IgG2
purity :
Protein G purified
species :
Mouse
gene symbol :
RARRES2
applications :
ELISA
USD :
539 USD
alt names :
chemerin, RAR-responsive protein TIG2, retinoic acid receptor responder (tazarotene induced) 2, retinoic acid receptor responder protein 2, Tazarotene-induced gene 2 protein, TIG2HP10433
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
browse more products
- KIR3DL1 Antibody (MM0443-1L34) [Allophycocyanin/Cy7] | NBP2-11763APCCY7
- Integrin beta 7 Antibody (2G18) [Allophycocyanin/Cy7] | NB110-94147APCCY7
- CD23/Fc epsilon RII Antibody (MM0164-2C23) [Allophycocyanin/Cy7] | NBP2-12152APCCY7
- LIGHT/TNFSF14 Antibody (MM0456-8C34) [PE/Cy7] | NBP2-11964PECY7
- Chemerin Antibody (13G2) [Alexa Fluor™ Plus 594] | NBP2-21989AFP594
questions and comments
